Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Am J Kidney Dis. 2013 Jun 5;62(3):541–548. doi: 10.1053/j.ajkd.2013.03.039

Table 3.

Adjusted Mean MCS score by eGFR category

eGFR category Model 1 Model 2 Model 3 Model 4 Model 5
≥90 mL/min/1.73 m2^ 50.71 (50.18, 51.24) 51.23 (50.58, 51.88) 50.91 (50.15, 51.68) 50.96 (50.20, 51.72) 50.48 (49.54, 51.41)
75–89 mL/min/1.73 m2 51.32 (50,88, 51.77) 51.06 (50.49, 51.64) 50.90 (50.21, 51.59) 50.80 (50.12, 51.49) 50.64 (49.82, 51.47)
60–74 mL/min/1.73 m2 51.47 (51.05, 51.89)* 51.25 (50.68, 51.83) 50.50 (49.82, 51.17) 50.44 (49.77, 51.12) 50.41 (49.60, 51.22)
45–59 mL/min/1.73 m2 50.90 (50.36, 51.45) 50.57 (49.88, 51.24) 50.58 (49.80, 51.37) 50.77 (49.99, 51.56) 50.99 (50.07, 51.91)
30–44 mL/min/1.73 m2 51.04 (50.21, 51.88) 51.10 (50.14, 52.07) 50.65 (49.56, 51.74) 51.19 (50.10, 52.28) 51.50 (50.22, 52.77)
≤29 mL/min/1.73 m2 48.18 (46.68, 49.68)* 48.12 (46.45, 49.78)* 47.52 (45.56, 49.48)* 48.58 (46.61, 50.54)* 49.04 (46.98, 51.11)
*

Indicates statistical significance (p<0.05) compared to the reference group.

^

Reference.

Note: Values are given as mean MCS score (95% confidence interval). Multivariable linear models included the following: in model 1, unadjusted regression analysis; in model 2, patient demographics (age, gender, race/ethnicity, marital status, household income, and education level); in model 3, additional adjustment for demographics and obesity, duration of diabetes and proteinuria; in model 4, fully-adjusted, including medical conditions and cardiovascular comorbidities: cerebrovascular disease, myocardial infarction, peripheral vascular disease, and coronary heart failure; and in model 5, mediation model with additional adjustment for baseline hemoglobin value.

MCS, mental component summary; eGFR, estimated glomerular filtration rate;